Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JANUARY 28, 2007 FBO #1889
SOLICITATION NOTICE

68 -- Purchase of materials/reagents required for whole genome sequencing using the Roche GS20 Pyrosequencer.

Notice Date
1/26/2007
 
Notice Type
Solicitation Notice
 
Contracting Office
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
 
ZIP Code
21702-5014
 
Solicitation Number
W81XWH07NBFAC
 
Response Due
2/12/2007
 
Archive Date
4/13/2007
 
Small Business Set-Aside
N/A
 
Description
The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate a sole source contract with Roche Diagnostics Corporation. The procurement will provide the National Biodefense Analysis and Countermeasures Center (NBFAC) with missi on critical reagents. The NBFAC is requesting Roche Diagnostics Corporation emPCR Kit, sequencing kit, PicoTiterPlate Kit, Library Prep Kit, and a large Bead Deposition Device. No other vendor distributes these reagents, which are required for whole genom e sequencing using the Roche GS20 Pyrosequencer. Any company that believes that it can meet these requirements is invited to submit written notification to the Contract Specialist within 15 calendar days from the date of the publication of this notice. Supporting evidence must be furnished in sufficie nt detail to demonstrate the companys ability to meet the requirement. Information may be sent by email to the Contract Specialist at: john.fitzsimmons@amedd.army.mil . This notice of intent is not a request for competitive quotes. However, responses r eceived from responsible businesses prior to close of business on 12 February 2007 will be evaluated. If no responses are received, USAMRAA will proceed with the sole source order. See numbered Note 22. 1. Contracting Activity: The contracting activity responsible for this action is the US Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, MD. On behalf of the National Bioforensic analysis Center (NBFAC). 2. Description of Action: This approval is being requested for a new firm-fixed price contract using R&D funds. 3. Description of Supplies/Services: The required supplies are materials/reagents required for whole genome sequencing using the Roche GS20 Pyrosequencer. NBFAC is requesting 40 emPCR Kits, 50 Sequencing (70x75) Kits, 50 PicoTiterPlate (70x75) Kits, 2 Lib rary Prep Kits, 2 Large (70x75) Bead Deposition Device complete 2 region. The total cost of the acquisition is $201,383.00 4. Authority Cited: The statutory authority permitting other than full and open competition is 10U.S.C 2304 ? (1). The FAR citation is 6.302-1 and the FAR title is only one responsible source and no other supplies or services will satisfy agency requireme nts. 5. Reason for Authority Cited: The proposed vendor for this action is Roche Diagnostics Corporation. Roche has the unique qualifications for fulfilling the contract requirements because they are the only vendor distributing the supplies/reagents cited abov e. No other vendor distributes these reagents 6. Efforts to Obtain Competition: Not applicable, NO effort will be made to solicit offers from as many potential sources as is practicable as there is only one source capable of performing the required services, given the need to ensure the consistency an d scientific quality of the assays to be performed. No effective competition is anticipated. 7. Actions to Increase Competition: To date no actions to increase competition have been initiated. Roche Diagnostics Corporations GS20 sequencing reagents are used in assays that are specifically designed for a machine distributed by Roche Diagnostic Co rporation. 8. Market Research: Market research was conducted to find additional suppliers of the Roche Diagnostics Corporation GS20 sequencing reagents. The sequencing reagents are specific to the machine being used and are distributed solely by Roche Diagnostic Cor poration. To maintain consistency in the results and quality of the assays, only Roche Diagnostics Corporation GS20 sequencing reagents can be used. Using reagents not supplied by Roche Diagnostics Corporation would violate the warranty of the Instrument . 9. Interested Sources: To date no other sources have written to express an interest. 10. Other Facts a. Procurement history: Reasonable efforts to retrieve the following items from computer records, contract files, competition advocate office files or other sources are ex pected: (1) Contract numbers and dates of the last several awards. Not applicable (2) Competitive status of these actions. Not applicable (3) Authority previously used for less than full and open competition. Not applicable (4) If a justification was prepared to support the procurement made before this one, a summary of the contents of paragraph 7 of the justification for that procurement and an explanation of the results. Not applicable (5) If any prior award was accomplished by full and open competition, a detailed explanation of the changed circumstances. Not applicable (6) An explanation of any unusual patterns which may be revealed by the history, e.g., several consecutive, urgent buys. Not applicable (7) If a justification was prepared to support the procurement made before this one, briefly describe the circumstances justifying the buy and whether there have been any significant changes. Not applicable b. Acquisition data availability: A statement of work suitable for full and open competition can be developed for this procurement. It is not being completed because in order to maintain the merit and validity of scientific research, there is only one sou rce that can render the service requested. c. Unusual and compelling urgency: Not applicable d. Subcontracting competition: Not applicable This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are b eing requested and a written solicitation will not be issued.
 
Place of Performance
Address: US Army Medical Research Acquisition Activity ATTN: MCMR-AAA, 820 Chandler Street Frederick MD
Zip Code: 21702-5014
Country: US
 
Record
SN01220178-W 20070128/070126221140 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.